Mergers & Acquisitions


Current filters:


Popular Filters

651 to 675 of 922 results

Colby Pharma acquires Othera


Colby Pharmaceutical, a privately held California-based biopharmaceutical company, says that it has acquired…

Colby PharmaceuticalMergers & AcquisitionsOthera PharmaceuticalsPharmaceutical

Illumina acquires UK's BlueGnome


US developer, manufacturer and marketer of life science tools and integrated systems for the analysis…

BlueGnomeIlluminaMergers & AcquisitionsPharmaceutical

Analyst insight: Sanofi eyes Columbia, Indonesia and Vietnam


Emerging markets, BRIC countries are words that have recently risen to prominence in a majority of pharmaceutical…

Asia-PacificLicensingMarkets & MarketingMergers & AcquisitionsPharmaceuticalSanofiSouth America

Johnson & Johnson to set up innovation centers to accelerate partnering


US health care giant Johnson & Johnson (NYSE: JNJ) yesterday said it plans to establish four regional…

Johnson & JohnsonLicensingMergers & AcquisitionsPharmaceuticalResearch

Bionomics buys US cancer stem cell firm Eclipse Therapeutics


Australian biotech firm Bionomics (ASX: BNO) has expanded its presence in the USA with the acquisition…

BionomicsBiotechnologyEclipse TherapeuticsMergers & AcquisitionsOncology

Pfizer launches generics JV in China with Hisun


Global drugs behemoth Pfizer (NYSE: PFE) and Zhejiang Hisun Pharmaceuticals (SSE Code: 600267), a leading…

Asia-PacificGenericsHisun-PfizerMergers & AcquisitionsPfizerPharmaceuticalZhejiang Hisun Pharma

Japan's vulnerable pharma companies, by P Reed Maurer


Once upon a time Japan's pharma companies could be compared to a convoy of ships. The big and small,…

Asia-PacificLicensingManagementMarkets & MarketingMergers & AcquisitionsPharmaceutical

Jazz Pharma sells women's health business to Meda for $95 million


US drugmaker Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced a definitive agreement to sell its women's…

Jazz PharmaceuticalsMedaMergers & AcquisitionsPharmaceuticalWomen's Health

Valeant on the prowl again, with bid to buy Medicis for about $2.6 billion


In a sixth acquisition so far this year, as well as several takeovers the previous year, Canada's Valeant…

DermatologicalsMedicis PharmaceuticalMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals

Mitsubishi Tanabe to take full control of Bipha JV


Japanese drug major Mitsubishi Tanabe Pharma (TYO: 4508) has agreed to acquire the 49% holding (20,580…

Bipha CorpMergers & AcquisitionsMitsubishi TanabePharmaceutical

Synergy Pharma gains rights to shingles drug from Bristol-Myers


US biopharma firm Synergy Pharmaceuticals (Nasdaq: SGYP) has signed an asset purchase agreement with…

Anti-viralsBiotechnologyBristol-Myers SquibbFV-100Mergers & AcquisitionsSynergy Pharmaceuticals

Merck KGaA acquires cell culture media specialist Biochrom


Germany's Merck KGaA (MRK: DE) announced yesterday that it has entered into definitive agreements to…

BiochromMerck KGaAMergers & AcquisitionsMilliporePharmaceutical

United Drug acquires Bilcare clinical trials materials business


Ireland-based health care services company United Drug (UDG: IR) announced yesterday that it has reached…

BilcareMergers & AcquisitionsPharmaceuticalUnited Drug

Cinven to acquire Mercury Pharma for $730 million


Cinven, a Channel Islands-based private equity firm, said last Friday that it has reached agreement to…

CinvenGenericsMercury PharmaMergers & AcquisitionsPharmaceutical

Stada Arz sells two Russian production facilities


German drugmaker Stada Arzneimittel (SAZ: GR) revealed this week that it has signed a contract and accompanying…

EuropeGenericsMergers & AcquisitionsPharmaceuticalProductionSTADA Arzneimittel

Aspen Pharmacare acquires portfolio from GSK in Australia for £172 million


South Africa headquartered Aspen Pharmacare (APN: SJ) revealed this morning that it has reached agreement…

Asia-PacificAspen PharmacareGlaxoSmithKlineMergers & AcquisitionsPharmaceutical

Cortex and Pier Pharma in all-share merger


USA-based neuroscience company Cortex Pharmaceuticals (OTCBB: CORX) and privately held biotech firm Pier…

BiotechnologyCortex PharmaceuticalsMergers & AcquisitionsNeurologicalPharmaceuticalPier Pharmaceuticals

651 to 675 of 922 results

Back to top